http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 10 Feb 2026 16:45:21 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Earnings/Sonoma+Pharmaceuticals+%28SNOA%29+Misses+Q3+EPS+by+43c/25976561.html <p>Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.48), $0.43 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $5.24 million.</p><p>For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) <a href="http://www.streetinsider.com/ec_earnings.php?q=SNOA">click here</a>.</p> http://www.streetinsider.com/Earnings/Sonoma+Pharmaceuticals+%28SNOA%29+Misses+Q3+EPS+by+43c/25976561.html Tue, 10 Feb 2026 16:45:21 -0500 SNOA http://www.streetinsider.com/Press+Releases/Sonoma+Pharmaceuticals+Reports+Third+Fiscal+Quarter+2026+Financial+Results/25975737.html <ul style="list-style-type:disc;"><li><p><i><strong>Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior year</strong></i></p></li><li><p><i><strong>Net loss and net loss per share decreased from prior year for both the three months and nine months ended December 31, 2025</strong></i></p></li><li><p><i><strong>EBITDAS loss decreased by $0.4 million and $0.9 million for the three and nine months ended December 31, 2025 compared to prior year</strong></i></p></li></ul><p><strong id="dateline">BOULDER, COLORADO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / February 10, 2026 / </strong>Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) http://www.streetinsider.com/Press+Releases/Sonoma+Pharmaceuticals+Reports+Third+Fiscal+Quarter+2026+Financial+Results/25975737.html Tue, 10 Feb 2026 16:10:00 -0500 SNOA http://www.streetinsider.com/ACCESS+Newswire/Sonoma+Pharmaceuticals+Reports+Third+Fiscal+Quarter+2026+Financial+Results/25975737.html <ul style="list-style-type:disc;"><li><p><i><strong>Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior year</strong></i></p></li><li><p><i><strong>Net loss and net loss per share decreased from prior year for both the three months and nine months ended December 31, 2025</strong></i></p></li><li><p><i><strong>EBITDAS loss decreased by $0.4 million and $0.9 million for the three and nine months ended December 31, 2025 compared to prior year</strong></i></p></li></ul><p><strong id="dateline">BOULDER, COLORADO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / February 10, 2026 / </strong>Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA),a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) http://www.streetinsider.com/ACCESS+Newswire/Sonoma+Pharmaceuticals+Reports+Third+Fiscal+Quarter+2026+Financial+Results/25975737.html Tue, 10 Feb 2026 16:10:00 -0500 SNOA http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sonoma+Pharmaceuticals%2C+++For%3A+Dec+31/25975389.html si-local-file:///var/storage/secattach/20260210/25975389.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sonoma+Pharmaceuticals%2C+++For%3A+Dec+31/25975389.html Tue, 10 Feb 2026 16:02:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sonoma+Pharmaceuticals%2C+++For%3A+Dec+31/25975389.html si-local-file:///var/storage/secattach/20260210/25975389.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Sonoma+Pharmaceuticals%2C+++For%3A+Dec+31/25975389.html Tue, 10 Feb 2026 16:02:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28++Filed+by%3A+Jacoby+Vanessa/25969042.html si-local-file:///var/storage/secattach/20260209/25969042.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28++Filed+by%3A+Jacoby+Vanessa/25969042.html Mon, 09 Feb 2026 17:00:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28++Filed+by%3A+Jacoby+Vanessa/25969042.html si-local-file:///var/storage/secattach/20260209/25969042.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28++Filed+by%3A+Jacoby+Vanessa/25969042.html Mon, 09 Feb 2026 17:00:00 -0500 O.00050851 SNOA http://www.streetinsider.com/Board+Changes/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html <p>Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) announced the appointment of Vanessa Jacoby to its board of directors and as chair of its audit committee. The company also named Arturo Angel as senior vice president of regulatory, quality and product development.</p><p>Jacoby currently serves as chief business and financial officer of Quanta Therapeutics Inc. She previously held senior financial roles at Shoreline Biosciences, where she established partnerships with Kite Pharma and BeiGene, and at Avidity Biosciences Inc. (NASDAQ: RNA), where she led the company's initial public offering process. Jacoby is a licensed CPA in California and began her career as an auditor at http://www.streetinsider.com/Board+Changes/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html Wed, 28 Jan 2026 16:16:46 -0500 RNA SNOA http://www.streetinsider.com/Board+Changes/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html <p>Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) announced the appointment of Vanessa Jacoby to its board of directors and as chair of its audit committee. The company also named Arturo Angel as senior vice president of regulatory, quality and product development.</p><p>Jacoby currently serves as chief business and financial officer of Quanta Therapeutics Inc. She previously held senior financial roles at Shoreline Biosciences, where she established partnerships with Kite Pharma and BeiGene, and at Avidity Biosciences Inc. (NASDAQ: RNA), where she led the company's initial public offering process. Jacoby is a licensed CPA in California and began her career as an auditor at http://www.streetinsider.com/Board+Changes/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html Wed, 28 Jan 2026 16:16:46 -0500 RNA SNOA http://www.streetinsider.com/Corporate+News/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html <p>Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) announced the appointment of Vanessa Jacoby to its board of directors and as chair of its audit committee. The company also named Arturo Angel as senior vice president of regulatory, quality and product development.</p><p>Jacoby currently serves as chief business and financial officer of Quanta Therapeutics Inc. She previously held senior financial roles at Shoreline Biosciences, where she established partnerships with Kite Pharma and BeiGene, and at Avidity Biosciences Inc. (NASDAQ: RNA), where she led the company's initial public offering process. Jacoby is a licensed CPA in California and began her career as an auditor at http://www.streetinsider.com/Corporate+News/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html Wed, 28 Jan 2026 16:16:46 -0500 RNA SNOA http://www.streetinsider.com/Corporate+News/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html <p>Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) announced the appointment of Vanessa Jacoby to its board of directors and as chair of its audit committee. The company also named Arturo Angel as senior vice president of regulatory, quality and product development.</p><p>Jacoby currently serves as chief business and financial officer of Quanta Therapeutics Inc. She previously held senior financial roles at Shoreline Biosciences, where she established partnerships with Kite Pharma and BeiGene, and at Avidity Biosciences Inc. (NASDAQ: RNA), where she led the company's initial public offering process. Jacoby is a licensed CPA in California and began her career as an auditor at http://www.streetinsider.com/Corporate+News/Sonoma+Pharmaceuticals+appoints+new+board+member+and+executive/25908884.html Wed, 28 Jan 2026 16:16:46 -0500 RNA SNOA http://www.streetinsider.com/Press+Releases/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html <p><strong id="dateline">BOULDER, CO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / January 28, 2026 / </strong>Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn^® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced the appointment of Vanessa Jacoby, Chief Business and Financial Officer of Quanta Therapeutics, Inc., to its Board of Directors and to serve as Chair of its Audit Committee. Sonoma also announced the retirement of its longtime director, Dr. Jay Birnbaum. Finally, Sonoma http://www.streetinsider.com/Press+Releases/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html Wed, 28 Jan 2026 16:15:00 -0500 RNA SNOA http://www.streetinsider.com/Press+Releases/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html <p><strong id="dateline">BOULDER, CO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / January 28, 2026 / </strong>Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn^® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced the appointment of Vanessa Jacoby, Chief Business and Financial Officer of Quanta Therapeutics, Inc., to its Board of Directors and to serve as Chair of its Audit Committee. Sonoma also announced the retirement of its longtime director, Dr. Jay Birnbaum. Finally, Sonoma http://www.streetinsider.com/Press+Releases/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html Wed, 28 Jan 2026 16:15:00 -0500 RNA SNOA http://www.streetinsider.com/ACCESS+Newswire/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html <p><strong id="dateline">BOULDER, CO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / January 28, 2026 / </strong>Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn^® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced the appointment of Vanessa Jacoby, Chief Business and Financial Officer of Quanta Therapeutics, Inc., to its Board of Directors and to serve as Chair of its Audit Committee. Sonoma also announced the retirement of its longtime director, Dr. Jay Birnbaum. Finally, Sonoma http://www.streetinsider.com/ACCESS+Newswire/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html Wed, 28 Jan 2026 16:15:00 -0500 RNA SNOA http://www.streetinsider.com/ACCESS+Newswire/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html <p><strong id="dateline">BOULDER, CO / <a href='https://www.accessnewswire.com/'>ACCESS Newswire</a> / January 28, 2026 / </strong>Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn^® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced the appointment of Vanessa Jacoby, Chief Business and Financial Officer of Quanta Therapeutics, Inc., to its Board of Directors and to serve as Chair of its Audit Committee. Sonoma also announced the retirement of its longtime director, Dr. Jay Birnbaum. Finally, Sonoma http://www.streetinsider.com/ACCESS+Newswire/Sonoma+Pharmaceuticals+Welcomes+New+Member+of+its+Board+of+Directors+and+New+Senior+Vice+President+of+Regulatory%2C+Quality+and+Product+Development/25908792.html Wed, 28 Jan 2026 16:15:00 -0500 RNA SNOA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28/25908476.html si-local-file:///var/storage/secattach/20260128/25908476.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28/25908476.html Wed, 28 Jan 2026 16:01:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28/25908476.html si-local-file:///var/storage/secattach/20260128/25908476.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+28/25908476.html Wed, 28 Jan 2026 16:01:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+12/25834948.html si-local-file:///var/storage/secattach/20260112/25834948.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+12/25834948.html Mon, 12 Jan 2026 08:31:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+12/25834948.html si-local-file:///var/storage/secattach/20260112/25834948.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+12/25834948.html Mon, 12 Jan 2026 08:31:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Weigerstorfer+Philippe/25799321.html si-local-file:///var/storage/secattach/20260102/25799321.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Weigerstorfer+Philippe/25799321.html Fri, 02 Jan 2026 17:25:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Weigerstorfer+Philippe/25799321.html si-local-file:///var/storage/secattach/20260102/25799321.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Weigerstorfer+Philippe/25799321.html Fri, 02 Jan 2026 17:25:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Trombly+Amy+Moss/25799317.html si-local-file:///var/storage/secattach/20260102/25799317.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Trombly+Amy+Moss/25799317.html Fri, 02 Jan 2026 17:24:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Trombly+Amy+Moss/25799317.html si-local-file:///var/storage/secattach/20260102/25799317.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+Trombly+Amy+Moss/25799317.html Fri, 02 Jan 2026 17:24:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+MCLAUGHLIN+JOHN/25799305.html si-local-file:///var/storage/secattach/20260102/25799305.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+MCLAUGHLIN+JOHN/25799305.html Fri, 02 Jan 2026 17:23:00 -0500 O.00050851 SNOA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+MCLAUGHLIN+JOHN/25799305.html si-local-file:///var/storage/secattach/20260102/25799305.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sonoma+Pharmaceuticals%2C+++For%3A+Jan+02++Filed+by%3A+MCLAUGHLIN+JOHN/25799305.html Fri, 02 Jan 2026 17:23:00 -0500 O.00050851 SNOA